ABM or CTAS: Which Is the Better Value Stock Right Now?

Zacks Investment Research analyzed ABM Industries (ABM) and Cintas (CTAS), both with a Zacks Rank of #2 (Buy), to determine which is the better value stock. ABM appears to be the superior value option based on several key metrics: ABM has a lower forward P/E ratio (13.58 vs. 50.75), a lower PEG ratio (2.63 vs. 3.85), and a lower P/B ratio (1.79 vs. 19.53) compared to Cintas; these metrics contribute to ABM's Value grade of B versus CTAS's Value grade of D.

Analysis

Both ABM Industries (ABM) and Cintas (CTAS), operating within the Business - Services sector, currently hold a Zacks Rank of #2 (Buy), indicating positive earnings estimate revisions and an improving earnings outlook for both companies. Despite this shared positive momentum, a comparative valuation analysis reveals significant differences. ABM presents a more compelling value proposition with a forward Price-to-Earnings (P/E) ratio of 13.58, considerably lower than CTAS's 50.75. Furthermore, ABM's Price/Earnings-to-Growth (PEG) ratio is 2.63, compared to 3.85 for CTAS, and its Price-to-Book (P/B) ratio stands at 1.79, markedly below CTAS's 19.53. These metrics contribute to ABM achieving a Zacks Value grade of B, while CTAS receives a D. Consequently, based purely on these valuation figures, ABM is identified as the superior value stock at this time. This assessment is further supported by a higher per-ticker sentiment score for ABM (0.7) compared to CTAS (0.2), aligning with the article's valuation-driven conclusion.

Key Decisions for Investors

• Value-focused investors should consider ABM Industries as a potentially more attractive investment compared to Cintas, given ABM's significantly lower P/E, PEG, and P/B ratios alongside a superior Zacks Value grade.
• While both companies have positive earnings outlooks indicated by their #2 (Buy) Zacks Rank, investors seeking exposure to the Business - Services sector with a stronger emphasis on current valuation metrics may find ABM a more compelling option than CTAS.
• Continue to monitor earnings estimate revisions and fundamental metric trends for both ABM and CTAS to ascertain if the current valuation disparity and growth outlooks persist or change.